NCT00720694View on ClinicalTrials.gov

Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome

PHASE3CompletedINTERVENTIONAL

Enrollment

250

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

May 31, 2007

Conditions

Plantar Fasciitis

Interventions

DEVICE

Duolith SD1

DEVICE

Sham Duolith SD1

Trial Locations (6)

10023

Galli Podiatric Foot and Ankle Associates, New York

44512

Ankle and Foot Care Centers, Boardman

94301

Palo Alto Medical Fondation, Palo Alto

98133

The Sports Medicine Clinic, Seattle

06518

Connecticut Orthopedics Specialists, Hamden

06470

Advanced Footcare Specialists of Connecticut, LLC, Newtown

All Listed Sponsors

lead

Storz Medical AG

INDUSTRY

NCT00720694 - Study of Effectiveness and Safety of Extracorporeal Shock Wave Therapy (ESWT) for Treatment of Painful Heel Syndrome | Biotech Hunter | Biotech Hunter